⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RARE News
Ultragenyx Pharmaceutical Inc.
The Same Pattern That Reshaped American Power Is Happening Again. And One Remote Deposit Is at the Center of It.
globenewswire.com
TRX
RARE
MitoRx Therapeutics presents promising preclinical data on MTRX31, a mitochondrial-targeted small molecule for metabolically unhealthy obesity, at the American Diabetes Association’s 2026 Scientific Sessions
globenewswire.com
LYFT
NVS
LLY
RARE
Lifshitz Law PLLC Announces Investigations of Kyndryl Holdings, Inc. (NYSE: KD), Corcept Therapeutics, Inc. (NASDAQ: CORT), NuScale Power Corporation (NYSE: SMR), and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE)
accessnewswire.com
KD
CORT
SMR
RARE
Kuehn Law Encourages Investors of Ultragenyx Pharmaceutical Inc. to Contact Law Firm
prnewswire.com
RARE
Ultragenyx to Participate at Goldman Sachs 47th Annual Global Healthcare Conference
globenewswire.com
RARE
Kuehn Law Encourages Investors of Ultragenyx Pharmaceutical Inc. to Contact Law Firm
globenewswire.com
RARE
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
RARE
Form 8-K
sec.gov
RARE
Amlogenyx Presents Preclinical Data on AM805, a Potentially Transformative Investigational Gene Therapy for Alzheimer’s Disease
globenewswire.com
RARE
Ultragenyx to Participate at Bank of America’s 2026 Healthcare Conference
globenewswire.com
RARE